https://edition.cnn.com/2020/07/14/health/moderna-coronavirus-vaccine-phase-1-st...Moderna coronavirus vaccine shows 'promising' safety and immune response results in published Phase 1 study, but more research is needed.
John Bonifield-Profile-Image
By Jacqueline Howard and John Bonifield, CNN
Updated 2124 GMT (0524 HKT) July 14, 2020
(CNN)A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.
These early results, published in the New England Journal of Medicine on Tuesday, showed that the vaccine worked to trigger an immune response with mild side effects -- fatigue, chills, headache, muscle pain, pain at the injection site -- becoming the first US vaccine candidate to publish results in a peer-reviewed medical journal
The vaccine is expected to begin later this month a large Phase 3 trial -- the final trial stage before regulators consider whether to make the vaccine available.
Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus.
Moderna noted in a press release on Tuesday that, if all goes well in future studies, "the Company remains on track to be able to deliver approximately 500 million doses per year, and possibly up to
1 billion doses per year, beginning in 2021."